We spoke to Jason Lacombe, CEO of Veratrak, from the Oxford Foundry's first accelerator cohort
It’s an eye-opening statistic: on average, 25% of the price of medication is caused by inefficiencies in the supply chain and bureaucracy of the pharmaceutical industry. These take many forms, from supply bottlenecks to incorrect labelling, leading to costly recalls.
Solve these problems and you stand to not only save the pharmaceutical industry millions of pounds a year, you can also make lifesaving medication cheaper for all. Enter Veratrak, brainchild of CEO Jason Lacombe, PhD student in population science at Hertford College, and one of the ten start-ups to win a place on the first ever OXFO L.E.V8 accelerator programme.